Pharma can optimize DTP strategies by leveraging data on affordability and patient behavior.
Jordan Armstrong
Advertisement
Jordan Armstrong is a VP of business development at AssistRX.
Articles by Jordan Armstrong
Jordan Armstrong outlines how adaptable DTP programs can reduce barriers and accelerate patient access to therapy.
Jordan Armstrong, VP of Business Development at AssistRX, explains how companies can tailor direct-to-patient strategies into their commercialization plans.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
How Specialty Growth and Cold Chain Demand Are Rewriting Distribution Strategy
2
Why Geopolitical Supply Chain Mapping Is Critical for Life Sciences
3
Commercial Trade's Expanding Mandate: From Product Movement to Commercial Performance
4
Pharma Pulse: Cardinal Health Bulks Up Home Care, Trump Unveils Phased Generics Tariffs
5